<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="18287,2181">L-Fucose</z:chebi> is a <z:chebi fb="1" ids="35381">monosaccharide</z:chebi> located at the non-reducing ends of sugar chains of glycoconjugates </plain></SENT>
<SENT sid="1" pm="."><plain>Urinary <z:chebi fb="0" ids="18287,2181">L-fucose</z:chebi> (U-FC) is excreted as free <z:chebi fb="0" ids="18287,2181">L-fucose</z:chebi>, and clinically useful as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> marker of digestive organ <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated the clinical usefulness of U-FC levels in patients with various <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> because U-FC for <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> has only rarely been described </plain></SENT>
<SENT sid="3" pm="."><plain>The mean U-FC levels in the <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ANLL), <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>) groups were significantly higher than in the control group (P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>Recently, we reported that urinary trypsin inhibitor (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e>) levels in patients with ANLL, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> were significantly elevated, compared with those in healthy adult volunteers </plain></SENT>
<SENT sid="5" pm="."><plain>Noninvasive combination assays of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> and U-FC may have a higher accuracy in diagnosis of ANLL and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> than those of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> or U-FC alone </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> and U-FC combination assays, noninvasive for patients, could be expanded as useful indicators in <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> </plain></SENT>
</text></document>